SPANIDIN

Welcome to the Brand page for “SPANIDIN”, which is offered here for In the statement, column 1, line 8, hyeractive should be deleted, and, hyperactive should be inserted.;pharmaceutical preparations for the use in the treatment of human diseases associated with the immune system, [ hyperactive ] * hyperactive * inflammatory disease, vasculitis, autoimmune disease, malaria, acute rejection, organ transplantation, aids and non-cancer degenerative disease;.

Its status is currently believed to be active. Its class is unavailable. “SPANIDIN” is believed to be currently owned by “NIPPON KAYAKU KABUSHIKI KAISHA”.


Owner:
NIPPON KAYAKU KABUSHIKI KAISHA
Owner Details
Description:
In the statement, column 1, line 8, hyeractive should be deleted, and, hyperactive should be inserted.;Pharmaceutical preparations for the use in the treatment of human diseases associated with the immune system, [ hyperactive ] * hyperactive * inflammatory disease, vasculitis, autoimmune disease, malaria, acute rejection, organ transplantation, AIDS and non-cancer degenerative disease;
Categories: STATEMENT